144 related articles for article (PubMed ID: 10691838)
1. Telomerase activity as a potential marker in preneoplastic bladder lesions.
Lancelin F; Anidjar M; Villette JM; Soliman A; Teillac P; Le Duc A; Fiet J; Cussenot O
BJU Int; 2000 Mar; 85(4):526-31. PubMed ID: 10691838
[TBL] [Abstract][Full Text] [Related]
2. Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urine.
Yoshida K; Sugino T; Tahara H; Woodman A; Bolodeoku J; Nargund V; Fellows G; Goodison S; Tahara E; Tarin D
Cancer; 1997 Jan; 79(2):362-9. PubMed ID: 9010110
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of bladder cancer using telomerase activity in voided urine.
Cheng CW; Chueh SC; Chern HD
J Formos Med Assoc; 2000 Dec; 99(12):920-5. PubMed ID: 11155745
[TBL] [Abstract][Full Text] [Related]
4. Detecting human bladder carcinoma cells in voided urine samples by assaying for the presence of telomerase activity.
Kavaler E; Landman J; Chang Y; Droller MJ; Liu BC
Cancer; 1998 Feb; 82(4):708-14. PubMed ID: 9477104
[TBL] [Abstract][Full Text] [Related]
5. Telomerase activity in malignant and benign bladder conditions.
Mayfield MP; Shah T; Flannigan GM; Hamilton Stewart PA; Bibby MC
Int J Mol Med; 1998 May; 1(5):835-40. PubMed ID: 9852304
[TBL] [Abstract][Full Text] [Related]
6. Semi-quantitative analysis of telomerase activity in exfoliated human urothelial cells and bladder transitional cell carcinoma.
Yokota K; Kanda K; Inoue Y; Kanayama H; Kagawa S
Br J Urol; 1998 Nov; 82(5):727-32. PubMed ID: 9839590
[TBL] [Abstract][Full Text] [Related]
7. [Detection of telomerase activity by semi-quantitative and in situ assays and quantification of hTERT expression in bladder carcinomas].
Longchampt E; Lebret T; Molinie V; Bieche I; Botto H; Lidereau R
Prog Urol; 2003 Apr; 13(2):238-45. PubMed ID: 12765058
[TBL] [Abstract][Full Text] [Related]
8. Telomerase activity is correlated with lower grade and lower stage bladder carcinomas.
Okumura A; Mizuno I; Nagakawa O; Fuse H
Int J Urol; 2004 Dec; 11(12):1082-6. PubMed ID: 15663679
[TBL] [Abstract][Full Text] [Related]
9. Telomerase activity in diagnosis of bladder cancer.
Erdem E; Dikmen G; Atsü N; Dogan P; Ozen H
Scand J Urol Nephrol; 2003; 37(3):205-9. PubMed ID: 12775275
[TBL] [Abstract][Full Text] [Related]
10. Telomerase activity: a potential marker of bladder transitional cell carcinoma in bladder washes.
Yang SC; Lee DH; Hong SJ; Chung BH; Kim IY
Yonsei Med J; 1997 Jun; 38(3):155-9. PubMed ID: 9259615
[TBL] [Abstract][Full Text] [Related]
11. A combination of semiquantitative telomerase assay and in-cell telomerase activity measurement using exfoliated urothelial cells for the detection of urothelial neoplasia.
Ohyashiki K; Yahata N; Ohyashiki JH; Iwama H; Hayashi S; Ando K; Aizawa T; Ito T; Miki M; Ebihara Y
Cancer; 1998 Dec; 83(12):2554-60. PubMed ID: 9874463
[TBL] [Abstract][Full Text] [Related]
12. [The role of telomerase activity in non-invasive diagnostics of bladder cancer].
Glybochko PV; Alyaev JG; Potoldykova NV; Polyakovsky KA; Vinarov AZ; Glukhov AI; Gordeev SA
Urologiia; 2016 Aug; (4):76-81. PubMed ID: 28247730
[TBL] [Abstract][Full Text] [Related]
13. Urine telomerase: an important marker in the diagnosis of bladder cancer.
Sanchini MA; Bravaccini S; Medri L; Gunelli R; Nanni O; Monti F; Baccarani PC; Ravaioli A; Bercovich E; Amadori D; Calistri D
Neoplasia; 2004; 6(3):234-9. PubMed ID: 15153335
[TBL] [Abstract][Full Text] [Related]
14. Possible role of telomerase and sFas in pathogenesis of various bladder lesions associated with schistosomiasis.
Shaker OG; Hammam O; Salehd A; el-Leithy T; Wishahi M
Clin Biochem; 2009 Jun; 42(9):864-72. PubMed ID: 19272297
[TBL] [Abstract][Full Text] [Related]
15. Telomerase activity as an indicator of malignant potential in iodine-nonreactive lesions of the esophagus.
Koyanagi K; Ozawa S; Ando N; Mukai M; Kitagawa Y; Ueda M; Kitajima M
Cancer; 2000 Apr; 88(7):1524-9. PubMed ID: 10738208
[TBL] [Abstract][Full Text] [Related]
16. Telomerase reverse transcriptase (TERT) promoter mutation analysis of benign, malignant and reactive urothelial lesions reveals a subpopulation of inverted papilloma with immortalizing genetic change.
Cheng L; Davidson DD; Wang M; Lopez-Beltran A; Montironi R; Wang L; Tan PH; MacLennan GT; Williamson SR; Zhang S
Histopathology; 2016 Jul; 69(1):107-13. PubMed ID: 26679899
[TBL] [Abstract][Full Text] [Related]
17. Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer.
Engelhardt M; Drullinsky P; Guillem J; Moore MA
Clin Cancer Res; 1997 Nov; 3(11):1931-41. PubMed ID: 9815582
[TBL] [Abstract][Full Text] [Related]
18. Detection of telomerase activity in exfoliated cancer cells in colonic luminal washings and its related clinical implications.
Yoshida K; Sugino T; Goodison S; Warren BF; Nolan D; Wadsworth S; Mortensen NJ; Toge T; Tahara E; Tarin D
Br J Cancer; 1997; 75(4):548-53. PubMed ID: 9052409
[TBL] [Abstract][Full Text] [Related]
19. Telomerase activity in human bladder tumors and bladder washing specimens.
Wu WJ; Liu LT; Huang CH; Chang SF; Chang LL
Kaohsiung J Med Sci; 2001 Dec; 17(12):602-9. PubMed ID: 12168493
[TBL] [Abstract][Full Text] [Related]
20. Detection of telomerase activity in exfoliated cells in urine from patients with bladder cancer.
Kinoshita H; Ogawa O; Kakehi Y; Mishina M; Mitsumori K; Itoh N; Yamada H; Terachi T; Yoshida O
J Natl Cancer Inst; 1997 May; 89(10):724-30. PubMed ID: 9168188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
